FHL3: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 12:35, 17 March 2025
FHL3 (Four and a half LIM domains 3) is a protein that in humans is encoded by the FHL3 gene. It is a member of the Four and a half LIM domains protein family, which is a group of proteins characterized by the presence of four LIM domains and an additional half LIM domain.
Function[edit]
FHL3 is a cytosolic protein that may be involved in specific cytoskeletal structures. This protein binds to the Rho family of GTPases, and may stimulate Rho-dependent signal transduction pathways. It is involved in the organization of actin filaments and in cell shape and motility.
Clinical significance[edit]
Mutations in the FHL3 gene have been associated with reducing the risk of developing muscular dystrophy, specifically X-linked recessive Emery-Dreifuss muscular dystrophy (EDMD).
See also[edit]
References[edit]
<references />
External links[edit]
